According to the statistical results, SLC7A11 overexpression was more frequently occurred in HCC patients with high preoperative serum AFP level, and unfavorable overall survival status (all 0.01 < P < 0.05, Table 1). This evidence concerns the gene SLC7A11 and hepatocellular carcinoma.